Macon Ridge Research Station, LSU AgCenter, Winnsboro, LA.
Department of Plant Pathology and Crop Physiology, LSU AgCenter, Baton Rouge, LA.
Plant Dis. 2024 Jan;108(1):149-161. doi: 10.1094/PDIS-03-23-0588-RE. Epub 2024 Jan 23.
Cercospora leaf blight (CLB) of soybean, caused by cf. , , and cf. , is an economically important disease in the southern United States. Cultivar resistance to CLB is inconsistent; therefore, fungicides in the quinone outside inhibitor (QoI) class have been relied on to manage the disease. Approximately 620 isolates from plants exhibiting CLB were collected between 2018 and 2021 from 19 locations in eight southern states. A novel polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay based on two genes, and , was developed to differentiate between the dominant species of , cf. , and cf. . A multilocus phylogenetic analysis of actin, calmodulin, histone h3, ITS rDNA, and transcription elongation factor 1-α was used to confirm PCR-RFLP results and identify remaining isolates. Approximately 80% of the isolates collected were identified as cf. , while 15% classified as cf. , 2% as , and 3% as previously unreported species associated with CLB in the United States. PCR-RFLP of cytochrome () identified QoI-resistance conferred by the G143A substitution. Approximately 64 to 83% of isolates were determined to be QoI-resistant, and all contained the G143A substitution. Results of discriminatory dose assays using azoxystrobin (1 ppm) were 100% consistent with PCR-RFLP results. To our knowledge, this constitutes the first report of QoI resistance in CLB pathogen populations from Alabama, Arkansas, Kentucky, Mississippi, Missouri, Tennessee, and Texas. In areas where high frequencies of resistance have been identified, QoI fungicides should be avoided, and fungicide products with alternative modes-of-action should be utilized in the absence of CLB-resistant soybean cultivars.
大豆尾孢叶斑病(CLB)由 cf. 、 、和 cf. 引起,是美国南部地区一种重要的经济病害。品种对 CLB 的抗性不一致;因此,一直依赖醌外抑制剂(QoI)类的杀菌剂来控制该病害。2018 年至 2021 年期间,从美国南部 8 个州的 19 个地点收集了约 620 株表现出 CLB 的植株。基于两个基因 和 ,开发了一种新的聚合酶链反应-限制性片段长度多态性(PCR-RFLP)检测方法,用于区分主要种,即 cf. 、 cf. 和 cf. 。肌动蛋白、钙调蛋白、组蛋白 h3、ITS rDNA 和转录延伸因子 1-α 的多位点系统发育分析用于确认 PCR-RFLP 结果并鉴定剩余的分离物。约 80%的分离物被鉴定为 cf. ,而 15%归类为 cf. ,2%为 ,3%为以前在美国与 CLB 相关的未报告的 种。细胞色素 c( )的 PCR-RFLP 鉴定了由 G143A 取代赋予的 QoI 抗性。约 64%至 83%的分离物被确定为 QoI 抗性,并且所有分离物都含有 G143A 取代。使用咯菌腈(1 ppm)进行区分剂量测定的结果与 PCR-RFLP 结果 100%一致。据我们所知,这是首次报道来自阿拉巴马州、阿肯色州、肯塔基州、密西西比州、密苏里州、田纳西州和得克萨斯州的 CLB 病原菌群体中的 QoI 抗性。在已确定高抗性频率的地区,应避免使用 QoI 杀菌剂,并且在没有 CLB 抗性大豆品种的情况下,应使用具有替代作用模式的杀菌剂产品。